Skip to main content

Tissue Tranglutaminase Test Industry Noted CAGR of ~17.5% By 2023

The Tissue Tranglutaminase Test Industry is expected to grow at a CAGR of ~17.5% during the forecast period.

Increasing prevalence of celiac disease drives the growth of the market. According to the World Gastroenterology Organization in 2016, 1% of the total population in western countries was diagnosed with the celiac diseases and the prevalence have substantially increased across the globe.


Competitive Analysis:

Some of key players profiled in the report are,
  • Quest Diagnostics Incorporated.
  • SQI Diagnostics
  • Trinity Biotech
  • ZEDIRA GmbH
  • Demeditec Diagnostics GmbH
  • ARUP Laboratories
  • Cell Science Systems
  • Bio-Rad Laboratories Inc.
  • Pfizer Inc.
  • Celimmune LLC.
  • and others.
Market Segmentation:
The global Tissue Tranglutaminase Testing Industry has been segmented on the basis types and end users.
Based on types, the market has been segmented into serological, biopsy testing, and others. The serological testing is sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and tissue transglutaminase (tTG) antibody- IgG, serum.

Based on the end users, the market has been segmented as hospitals & clinics, homecare, research organizations, and others.

Table Of Contents

Report Prologue
Introduction
Research Methodology
Market Dynamics
Market Factor Analysis
Global Tissue Tranglutaminase Testing Industry, By Type
Serological Testing
Tissue Transglutaminase (TTG) Antibodies, IgA, Serum
 Tissue Transglutaminase (TTG) Antibody, IgG, Serum
Others.
…To be Continued

Comments

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...